Lamotrigine

Product NDC: 0115-1529
11-digit product format: 001151529
Labeler code: 0115
Product ID: 0115-1529_9611e358-6fe1-4f8d-99a2-250a7862a896
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: LAMOTRIGINE
Dosage form: TABLET, ORALLY DISINTEGRATING
Route: ORAL
Labeler: Amneal Pharmaceuticals of New York LLC
Application: ANDA200828
Marketing category: ANDA
Marketing start: 2015-01-09
Substance: LAMOTRIGINE
Active strength: 200 mg/1
Pharmacologic classes: Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A200828-001	LAMOTRIGINE	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15
A200828-002	LAMOTRIGINE	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15
A200828-003	LAMOTRIGINE	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15
A200828-004	LAMOTRIGINE	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A200828-001	AB
A200828-002	AB
A200828-003	AB
A200828-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL	AB	2013-07-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A200828-001	LAMOTRIGINE	25MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A200828-002	LAMOTRIGINE	50MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A200828-003	LAMOTRIGINE	100MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A200828-004	LAMOTRIGINE	200MG	TABLET, ORALLY DISINTEGRATING / ORAL		2013-07-15	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A200828-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200828-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200828-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A200828-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200828-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A200828-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200828-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200828-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A200828-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200828-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200828-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200828-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200828-004	AB	1	`2680178bc6a6…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200828-004	AB	1	`d8e5a09893c0…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200828-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200828-002	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200828-003	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200828-004	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A200828-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A200828-002	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A200828-003	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A200828-004	AB	1	`5d02ea3f76ae…`

Additional Listing Data#

Finished product: Yes
Brand name base: Lamotrigine
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LAMOTRIGINE	200 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
U3H27498KS	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
103968	Internal RxNorm lookup
198430	Internal RxNorm lookup
252478	Internal RxNorm lookup
252479	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
380bddae-5b31-4965-96de-97711d859d11	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
14a9502b-3d70-0496-a7e1-b16edaa005b8	Product name	5	20250423
16d731ed-ff3e-e9a1-3e3e-1ef6b6be40a0	Product name	7	20250401
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508
e29d8e8b-4bc8-ebaf-f18e-e35287b19d6a	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0115-1529-08	Lamotrigine	3 in 1 CARTON	TABLET, ORALLY DISINTEGRATING	3		13
0115-1529-15	Lamotrigine	10 in 1 BLISTER PACK	TABLET, ORALLY DISINTEGRATING	10		13

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0115-1529-08	EA - Each	0115-1529	9f7caa64-a9ae-4ea3-9861-e19d4fa15209	1	2015-03-03
0115-1529-15	EA - Each	0115-1529	00b08cab-8a0c-45f7-b9fc-448caa6991ad	1	2018-05-09

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LAMOTRIGINE	ACTIVE INGREDIENT	U3H27498KS	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]	1
LAMOTRIGINE	ACTIVE MOIETY	U3H27498KS	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]	1
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]	1
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER	INACTIVE INGREDIENT	905HNO1SIH	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]	1
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]	1
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0115-1529	LAMOTRIGINE TABLET, ORALLY DISINTEGRATING [AMNEAL PHARMACEUTICALS OF NEW YORK LLC]	13	Current NDC, Legacy NDC, 2 package rows	20240101_380bddae-5b31-4965-96de-97711d859d11.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lamotrigine	LAMOTRIGINE	Amneal Pharmaceuticals of New York LLC	9e5c2d76-47a6-4a57-b23c-2398b307380c	2025-12-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 200828 application number: ANDA200828
Lamotrigine	LAMOTRIGINE	Amneal Pharmaceuticals of New York LLC	380bddae-5b31-4965-96de-97711d859d11	2016-02-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 200828 application number: ANDA200828 ndc (product): 0115-1529

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
U3H27498KS	LAMOTRIGINE	84057-84-1	LAMOTRIGINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
103968	lamoTRIgine 100 MG Disintegrating Oral Tablet	PSN	380bddae-5b31-4965-96de-97711d859d11	13
252479	lamoTRIgine 200 MG Disintegrating Oral Tablet	PSN	380bddae-5b31-4965-96de-97711d859d11	13
198430	lamoTRIgine 25 MG Disintegrating Oral Tablet	PSN	380bddae-5b31-4965-96de-97711d859d11	13
252478	lamoTRIgine 50 MG Disintegrating Oral Tablet	PSN	380bddae-5b31-4965-96de-97711d859d11	13
103968	lamotrigine 100 MG Disintegrating Oral Tablet	SCD	380bddae-5b31-4965-96de-97711d859d11	13
252479	lamotrigine 200 MG Disintegrating Oral Tablet	SCD	380bddae-5b31-4965-96de-97711d859d11	13
198430	lamotrigine 25 MG Disintegrating Oral Tablet	SCD	380bddae-5b31-4965-96de-97711d859d11	13
252478	lamotrigine 50 MG Disintegrating Oral Tablet	SCD	380bddae-5b31-4965-96de-97711d859d11	13

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0115-1529-08	00115152908	3 BLISTER PACK in 1 CARTON (0115-1529-08) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0115-1529-15)	3 blister pack	2015-01-09	0000-00-00	No	No	Current
0115-1529-15	00115152915	10 in 1 BLISTER PACK						Historical